$MNKD
MANNKIND CORP Stock $mnkd

$mnkd Overview Financials Valuation SEC Filings Company Website

2014 Q1 Form 10-K Financial Statement

#000119312514080324 Filed on March 03, 2014

Income Statement

Concept	2014 Q1	2013	2012 Q4
Revenue	$0.00	$0.00	$0.00
YoY Change		-100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$15.20M	$59.70M	$10.40M
YoY Change	52.0%	53.08%	0.0%
% of Gross Profit
Research & Development	$26.18M	$109.7M	$25.30M
YoY Change	-0.82%	8.07%	23.41%
% of Gross Profit
Depreciation & Amortization	$2.500M	$11.50M	$3.470M
YoY Change	-16.39%	-11.54%	-8.92%
% of Gross Profit
Operating Expenses	$41.41M	$169.4M	$35.60M
YoY Change	13.65%	15.24%	14.84%
Operating Profit	-$41.41M	-$169.4M
YoY Change	13.65%	15.27%
Interest Expense	-$4.800M	$21.50M	-$5.000M
YoY Change	4.35%	-0.46%	-15.25%
% of Operating Profit
Other Income/Expense, Net	-$5.890M	-$635.0K	-$13.30M
YoY Change	-25708.7%	-46.68%	-13400.0%
Pretax Income	-$52.06M	-$191.5M	-$51.80M
YoY Change	27.07%	12.79%	42.31%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$52.06M	-$191.5M	-$51.78M
YoY Change	27.07%	13.06%	42.27%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$706.0K	-$3.197M	-$1.126M
COMMON SHARES
Basic Shares Outstanding	377.2M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2014 Q1	2013	2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$35.80M	$70.80M	$61.80M
YoY Change	27.86%	14.56%	2188.89%
Cash & Equivalents	$35.76M	$70.80M	$61.84M
Short-Term Investments			$60.80M
Other Short-Term Assets	$3.600M	$5.500M	$4.500M
YoY Change	-5.26%	22.22%	45.16%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$39.40M	$76.30M	$66.81M
YoY Change	22.04%	14.22%	1047.74%
LONG-TERM ASSETS
Property, Plant & Equipment	$176.3M	$176.6M	$184.0M
YoY Change	-3.27%	-4.02%	-4.7%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$8.437M	$5.800M	$230.0K
YoY Change	3568.26%	1060.0%	0.0%
Total Long-Term Assets	$185.2M	$182.3M	$184.5M
YoY Change	1.23%	-1.19%	-4.76%
TOTAL ASSETS
Total Short-Term Assets	$39.40M	$76.30M	$66.81M
Total Long-Term Assets	$185.2M	$182.3M	$184.5M
Total Assets	$224.6M	$258.6M	$251.3M
YoY Change	4.35%	2.9%	25.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.638M	$3.900M	$4.555M
YoY Change	0.94%	-15.22%	-1.49%
Accrued Expenses	$15.01M	$15.60M	$25.78M
YoY Change	-43.11%	-24.27%	24.31%
Deferred Revenue
YoY Change
Short-Term Debt	$25.90M	$102.3M	$0.00
YoY Change	-78.34%
Long-Term Debt Due		$0.00	$114.4M
YoY Change		-100.0%
Total Short-Term Liabilities	$44.52M	$127.8M	$144.8M
YoY Change	-83.15%	-11.74%	470.88%
LONG-TERM LIABILITIES
Long-Term Debt	$148.2M	$148.0M	$217.2M
YoY Change	51.53%	-31.86%	-55.47%
Other Long-Term Liabilities	$14.32M	$13.60M
YoY Change
Total Long-Term Liabilities	$14.32M	$161.6M	$217.2M
YoY Change	-85.36%	-25.6%	-55.47%
TOTAL LIABILITIES
Total Short-Term Liabilities	$44.52M	$127.8M	$144.8M
Total Long-Term Liabilities	$14.32M	$161.6M	$217.2M
Total Liabilities	$207.0M	$289.4M	$362.0M
YoY Change	-42.81%	-20.06%	-29.46%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$2.366B		$1.994B
YoY Change	18.35%		22.96%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$17.54M	-$30.70M	-$110.7M
YoY Change
Total Liabilities & Shareholders Equity	$224.6M	$258.6M	$251.3M
YoY Change	4.35%	2.9%	25.94%

Cashflow Statement

Concept	2014 Q1	2013	2012 Q4
OPERATING ACTIVITIES
Net Income	-$52.06M	-$191.5M	-$51.78M
YoY Change	27.07%	13.06%	42.27%
Depreciation, Depletion And Amortization	$2.500M	$11.50M	$3.470M
YoY Change	-16.39%	-11.54%	-8.92%
Cash From Operating Activities	-$36.99M	-$128.7M	-$28.10M
YoY Change	15.5%	7.4%	38.02%
INVESTING ACTIVITIES
Capital Expenditures	$1.409M	$7.987M	-$70.00K
YoY Change	-3.43%	1153.85%	-56.25%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$10.00K
YoY Change		-100.0%	-66.67%
Cash From Investing Activities	-$1.410M	-$7.987M	-$60.00K
YoY Change	-3.36%	1326.25%	-53.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$49.99M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.370M	145.7M	88.23M
YoY Change	-1065.62%	-18.88%	23745.95%
NET CHANGE
Cash From Operating Activities	-36.99M	-128.7M	-28.10M
Cash From Investing Activities	-1.410M	-7.987M	-60.00K
Cash From Financing Activities	3.370M	145.7M	88.23M
Net Change In Cash	-35.03M	8.950M	60.07M
YoY Change	3.53%	-84.87%	-398.56%
FREE CASH FLOW
Cash From Operating Activities	-$36.99M	-$128.7M	-$28.10M
Capital Expenditures	$1.409M	$7.987M	-$70.00K
Free Cash Flow	-$38.40M	-$136.7M	-$28.03M
YoY Change	14.67%	13.46%	38.76%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2012Q1	mnkd	Units Sold Warrant Portion Convertible Into Common Stock UnitsSoldWarrantPortionConvertibleIntoCommonStock	0.6
CY2012Q1	mnkd	Issuance Of Common Stock And Warrants Gross Value IssuanceOfCommonStockAndWarrantsGrossValue	86300000
CY2012Q1	mnkd	Units Sold Under Public Offer Underwritten UnitsSoldUnderPublicOfferUnderwritten	35937500	shares
CY2012Q1	mnkd	Restricted Stock Agreed To Be Purchased By Lender RestrictedStockAgreedToBePurchasedByLender	77200000
CY2012Q1	mnkd	Units Sold Under Public Offer Underwritten Composition Description UnitsSoldUnderPublicOfferUnderwrittenCompositionDescription	Each unit consisting of one share of common stock and a warrant to purchase 0.6 of a share of common stock
CY2012Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000	shares
CY2012Q2	mnkd	Fair Value Of Units Issued FairValueOfUnitsIssued	1.69
CY2012Q2	mnkd	Fair Value Input Discount For Lack Of Marketability FairValueInputDiscountForLackOfMarketability	0.0042	pure
CY1999Q4	us-gaap	Stockholders Equity StockholdersEquity	-746000
CY2000Q4	us-gaap	Stockholders Equity StockholdersEquity	31890000
CY2014Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	377208424	shares
CY2012Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000	shares
CY2012Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	31250000	shares
CY2013Q2	dei	Entity Public Float EntityPublicFloat	1153987371
CY2004Q3	mnkd	Operating Loss Carryforwards Subject To Limitation OperatingLossCarryforwardsSubjectToLimitation	216000000
CY2010Q4	us-gaap	Stockholders Equity StockholdersEquity	-185532000
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	66061000
CY2012Q2	mnkd	Restricted Stock Agreed To Be Purchased By Lender RestrictedStockAgreedToBePurchasedByLender	77200000
CY2012Q3	mnkd	Fair Value Assumption Risk Free Interest Rate FairValueAssumptionRiskFreeInterestRate	0.001	pure
CY2012Q3	mnkd	Loss Contingency Settlement Agreement Stock Consideration LossContingencySettlementAgreementStockConsideration	8600000
CY2012Q3	mnkd	Fair Value Assumption Expected Volatility Rate FairValueAssumptionExpectedVolatilityRate	0.54	pure
CY2012Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	2.60
CY1992Q1	us-gaap	Stockholders Equity StockholdersEquity	-11000
CY1993Q1	us-gaap	Stockholders Equity StockholdersEquity	-278000
CY1994Q1	us-gaap	Stockholders Equity StockholdersEquity	-908000
CY1994Q4	us-gaap	Stockholders Equity StockholdersEquity	-707000
CY1995Q4	us-gaap	Stockholders Equity StockholdersEquity	-3108000
CY1996Q4	us-gaap	Stockholders Equity StockholdersEquity	-5481000
CY1997Q4	us-gaap	Stockholders Equity StockholdersEquity	-7368000
CY1998Q4	us-gaap	Stockholders Equity StockholdersEquity	3404000
CY2001Q4	us-gaap	Goodwill Goodwill	151400000
CY2001Q4	us-gaap	Stockholders Equity StockholdersEquity	235018000
CY2002Q4	us-gaap	Stockholders Equity StockholdersEquity	90773000
CY2003Q4	us-gaap	Stockholders Equity StockholdersEquity	111577000
CY2004Q4	us-gaap	Stockholders Equity StockholdersEquity	150363000
CY2005Q4	us-gaap	Stockholders Equity StockholdersEquity	206977000
CY2006Q4	us-gaap	Stockholders Equity StockholdersEquity	383487000
CY2007Q4	us-gaap	Stockholders Equity StockholdersEquity	364100000
CY2008Q4	us-gaap	Stockholders Equity StockholdersEquity	86734000
CY2009Q4	us-gaap	Stockholders Equity StockholdersEquity	-59221000
CY2011Q4	us-gaap	Ownshare Lending Arrangement Shares Outstanding OwnshareLendingArrangementSharesOutstanding	9000000	shares
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	-313652000
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2681000
CY2011Q4	mnkd	Estimated Amounts Credit Exchange Receivable EstimatedAmountsCreditExchangeReceivable	609000
CY2011Q4	mnkd	Shares Reserved For Employee Stock Purchase Plan SharesReservedForEmployeeStockPurchasePlan	700000	shares
CY2011Q4	mnkd	Common Stock Loaned Under Share Lending Agreement Shares CommonStockLoanedUnderShareLendingAgreementShares	9000000	shares
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	550000000	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	286035082	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	3761031	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.46
CY2012Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	18674539	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	3.73
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2012Q4	us-gaap	Ownshare Lending Arrangement Shares Outstanding OwnshareLendingArrangementSharesOutstanding	9000000	shares
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	550000000	shares
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	286035082	shares
CY2012Q4	us-gaap	Ownshare Lending Arrangement Shares Issued OwnshareLendingArrangementSharesIssued	9000000	shares
CY2012Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	212026000
CY2012Q4	us-gaap	Interest Payable Current InterestPayableCurrent	4533000
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	144775000
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-6000
CY2012Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	10074000
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	101249000
CY2012Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1297000
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4555000
CY2012Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	750151000
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	-110679000
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1991379000
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	25777000
CY2012Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	97583000
CY2012Q4	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	119635000
CY2012Q4	us-gaap	Liabilities Liabilities	361993000
CY2012Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	114443000
CY2012Q4	us-gaap	Construction Payable Current ConstructionPayableCurrent	3878000
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	2860000
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	251314000
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	230000
CY2012Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	609471000
CY2012Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	750151000
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	30928000
CY2012Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet
CY2012Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	285210000
CY2012Q4	us-gaap	Nontrade Receivables Noncurrent NontradeReceivablesNoncurrent	313000
CY2012Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	3134000
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	183961000
CY2012Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	61800000
CY2012Q4	us-gaap	Assets Assets	251314000
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	61840000
CY2012Q4	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	450000
CY2012Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	65315000
CY2012Q4	us-gaap	Development Stage Enterprise Deficit Accumulated During Development Stage DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage	2104912000
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	4867000
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	2922000
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4520000
CY2012Q4	us-gaap	Assets Current AssetsCurrent	66810000
CY2012Q4	mnkd	Fair Value Of Units Issued FairValueOfUnitsIssued	2.40
CY2012Q4	mnkd	Increase Decrease In Fair Value Recognized In Other Income IncreaseDecreaseInFairValueRecognizedInOtherIncome	12000000
CY2012Q4	mnkd	Accrued Research And Clinical Trial Costs AccruedResearchAndClinicalTrialCosts	5995000
CY2012Q4	mnkd	Deferred Tax Assets Capitalized Research Expenses DeferredTaxAssetsCapitalizedResearchExpenses	31490000
CY2012Q4	mnkd	Available Borrowings Under Loan Agreement AvailableBorrowingsUnderLoanAgreement	125400000
CY2012Q4	mnkd	Estimated Amounts Credit Exchange Receivable EstimatedAmountsCreditExchangeReceivable	289000
CY2012Q4	mnkd	Loss Contingency Settlement Agreement Stock Consideration Fair Value LossContingencySettlementAgreementStockConsiderationFairValue	6492056
CY2012Q4	mnkd	Loss Contingency Settlement Agreement Stock Consideration LossContingencySettlementAgreementStockConsideration	8600000
CY2012Q4	mnkd	Accrued Interest Of Related Party Debt AccruedInterestOfRelatedPartyDebt	2200000
CY2012Q4	mnkd	Shares Reserved For Employee Stock Purchase Plan SharesReservedForEmployeeStockPurchasePlan	700000	shares
CY2012Q4	mnkd	Common Stock Loaned Under Share Lending Agreement Shares CommonStockLoanedUnderShareLendingAgreementShares	9000000	shares
CY2012Q4	mnkd	Deferred Tax Assets Capitalized Costs DeferredTaxAssetsCapitalizedCosts	6891000
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	369391972	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	9115821	shares
CY2013Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	12358495	shares
CY2013Q4	us-gaap	Derivative Number Of Instruments Held DerivativeNumberOfInstrumentsHeld	4	Derivative
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.35
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	24237940	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	13590564	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	3.90
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	4.35
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.36
CY2013Q4	us-gaap	Ownshare Lending Arrangement Shares Outstanding OwnshareLendingArrangementSharesOutstanding	9000000	shares
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	550000000	shares
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2013Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	32843733	shares
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	23533436	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	369391972	shares
CY2013Q4	us-gaap	Ownshare Lending Arrangement Shares Issued OwnshareLendingArrangementSharesIssued	9000000	shares
CY2013Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	98439000
CY2013Q4	us-gaap	Interest Payable Current InterestPayableCurrent	2082000
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	3578000
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5485000
CY2013Q4	us-gaap	Assets Current AssetsCurrent	76275000
CY2013Q4	mnkd	Derivatives Fair Value Liability Shares Issuable To Lender DerivativesFairValueLiabilitySharesIssuableToLender	16500000	shares
CY2013Q4	us-gaap	Construction Payable Current ConstructionPayableCurrent	342000
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	3697000
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	258646000
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5516000
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	127794000
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4000
CY2013Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	12193000
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	111060000
CY2013Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	5706000
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3860000
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	817000000
CY2013Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	13605000
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	-30713000
CY2013Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	102300000
CY2013Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2261996000
CY2013Q4	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	30100000
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	21634000
CY2013Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	98439000
CY2013Q4	us-gaap	Line Of Credit LineOfCredit	113500000
CY2013Q4	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	49521000
CY2013Q4	us-gaap	Liabilities Liabilities	289359000
CY2013Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	653896000
CY2013Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	1200000000
CY2013Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	817000000
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	41219000
CY2013Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	287617000
CY2013Q4	us-gaap	Nontrade Receivables Noncurrent NontradeReceivablesNoncurrent	298000
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	837000
CY2013Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2539000
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	176557000
CY2013Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	70800000
CY2013Q4	us-gaap	Assets Assets	258646000
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	40972000
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	70790000
CY2013Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	70091000
CY2013Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	22126000
CY2013Q4	us-gaap	Development Stage Enterprise Deficit Accumulated During Development Stage DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage	2296402000
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	40972000
CY2013Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	1700000000
CY2013Q4	mnkd	Accrued Research And Clinical Trial Costs AccruedResearchAndClinicalTrialCosts	1311000
CY2013Q4	mnkd	Loan Commitment Asset LoanCommitmentAsset	13393000
CY2013Q4	mnkd	Deferred Tax Assets Capitalized Research Expenses DeferredTaxAssetsCapitalizedResearchExpenses	30421000
CY2013Q4	mnkd	Available Borrowings Under Loan Agreement AvailableBorrowingsUnderLoanAgreement	30100000
CY2013Q4	mnkd	Estimated Amounts Credit Exchange Receivable EstimatedAmountsCreditExchangeReceivable	282000
CY2013Q4	mnkd	Share Based Compensation Arrangement Restricted Stock Units Number Of Units Expected To Vest ShareBasedCompensationArrangementRestrictedStockUnitsNumberOfUnitsExpectedToVest	8761363	shares
CY2013Q4	mnkd	Accrued Interest Of Related Party Debt AccruedInterestOfRelatedPartyDebt	600000
CY2013Q4	mnkd	Weighted Average Grant Date Fair Value Of Restricted Stock Units Expected To Vest WeightedAverageGrantDateFairValueOfRestrictedStockUnitsExpectedToVest	3.40
CY2013Q4	mnkd	Shares Reserved For Employee Stock Purchase Plan SharesReservedForEmployeeStockPurchasePlan	700000	shares
CY2013Q4	mnkd	Common Stock Loaned Under Share Lending Agreement Shares CommonStockLoanedUnderShareLendingAgreementShares	9000000	shares
CY2013Q4	mnkd	Deferred Tax Assets Capitalized Costs DeferredTaxAssetsCapitalizedCosts	7811000
CY2013Q4	mnkd	Loan Commitment Asset Noncurrent Portion LoanCommitmentAssetNoncurrentPortion	5157000
CY2013Q4	mnkd	Deferred Tax Assets Milestone Rights DeferredTaxAssetsMilestoneRights	6608000
CY2011Q1	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated RestructuringAndRelatedCostNumberOfPositionsEliminated	257	Employee
CY2011Q1	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated Period Percent RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent	0.41	pure
CY2011Q1	us-gaap	Restructuring Charges RestructuringCharges	6700000
CY2012Q1	mnkd	Proceeds From Issuance Of Common Stock And Warrants ProceedsFromIssuanceOfCommonStockAndWarrants	80600000
CY2012Q2	us-gaap	Forward Contract Indexed To Issuers Equity Shares ForwardContractIndexedToIssuersEquityShares	250000000	shares
CY2012Q4	us-gaap	Fair Value Inputs Discount Rate FairValueInputsDiscountRate	0.023	pure
CY2012Q4	us-gaap	Fair Value Assumptions Risk Free Interest Rate FairValueAssumptionsRiskFreeInterestRate	0.0011	pure
CY2001Q4	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	19700000
CY2012Q4	us-gaap	Fair Value Inputs Discount Rate FairValueInputsDiscountRate	0.015	pure
CY2012Q4	us-gaap	Fair Value Assumptions Risk Free Interest Rate FairValueAssumptionsRiskFreeInterestRate	0.0000	pure
CY2012Q4	us-gaap	Forward Contract Indexed To Issuers Equity Shares ForwardContractIndexedToIssuersEquityShares	350000000	shares
CY2013Q4	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	115000000
	mnkd	Stock Price Used To Forecast Future Liability StockPriceUsedToForecastFutureLiability	1.00
	mnkd	Loss Contingency Settlement Agreement Stock Issuable LossContingencySettlementAgreementStockIssuable	901000	shares
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1805000
	us-gaap	Net Income Loss NetIncomeLoss	-2004000
	mnkd	Notes Receivable From Stockholders Collection Of Stock Subscription NotesReceivableFromStockholdersCollectionOfStockSubscription	400000
CY2004Q1	mnkd	Percentage Of Common Stock Shares Outstanding PercentageOfCommonStockSharesOutstanding	0.01	pure
CY2012Q2	us-gaap	Forward Contract Indexed To Issuers Equity Shares ForwardContractIndexedToIssuersEquityShares	250000000	shares
CY2004Q3	mnkd	Net Operating Loss Carryforward Annual Limitation NetOperatingLossCarryforwardAnnualLimitation	13000000
CY2012Q4	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	40000000	shares
CY2012Q4	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	92000000
CY2012Q4	mnkd	Warrant Expiration Month Year WarrantExpirationMonthYear	2013-10
CY2012Q4	mnkd	Net Proceeds From Public Offering NetProceedsFromPublicOffering	86300000
CY2012Q4	mnkd	Additional Purchase Of Common Stock AdditionalPurchaseOfCommonStock	4500000	shares
CY2012Q4	mnkd	Common Stock Purchase CommonStockPurchase	30000000	shares
CY2012Q4	mnkd	Number Of Shares Of Common Stock In Each Unit NumberOfSharesOfCommonStockInEachUnit	1	shares
CY2012Q4	mnkd	Common Stock Issuable Upon Exercise Of Warrants Conversion Ratio CommonStockIssuableUponExerciseOfWarrantsConversionRatio	0.75	pure
CY2012Q4	mnkd	Additional Commons Stock Shares Issued During Period AdditionalCommonsStockSharesIssuedDuringPeriod	6000000	shares
CY2013Q4	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	89700000
CY2002Q4	mnkd	Headcount Reduction Percentage HeadcountReductionPercentage	0.50	pure
CY2009Q4	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-12800000
CY2012Q4	us-gaap	Forward Contract Indexed To Issuers Equity Shares ForwardContractIndexedToIssuersEquityShares	350000000	shares
CY2010	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	14335000
CY2010	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	361000
CY2010	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	924000
CY2010	us-gaap	Gain Loss On Foreign Currency Derivatives Recorded In Earnings Net GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet	-1600000
CY2010	us-gaap	Net Income Loss NetIncomeLoss	-170560000
CY2010	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-3392000
CY2010	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-6000
CY2010	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	16681000
CY2010	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1605000
CY2010	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13580000
CY2010	us-gaap	Unrealized Loss On Foreign Currency Derivatives Before Tax UnrealizedLossOnForeignCurrencyDerivativesBeforeTax	200000
CY2010	mnkd	Stock Issued During Period Value Share Lending Agreement StockIssuedDuringPeriodValueShareLendingAgreement	161000
CY1993	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	888000
CY1993	us-gaap	Net Income Loss NetIncomeLoss	-1175000
CY1993	mnkd	Adjustments To Additional Paid In Capital Contribution AdjustmentsToAdditionalPaidInCapitalContribution	20000
CY1994	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	526000
CY1994	us-gaap	Net Income Loss NetIncomeLoss	-1156000
CY1994	mnkd	Stock Issued During Period Shares Notes Receivable StockIssuedDuringPeriodSharesNotesReceivable		shares
CY1995	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	22000
CY1995	us-gaap	Net Income Loss NetIncomeLoss	-2815000
CY1995	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	384000
CY1995	mnkd	Stock Issued During Period Value Services StockIssuedDuringPeriodValueServices	8000
CY1997	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	196000
CY1997	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	135000
CY1997	us-gaap	Net Income Loss NetIncomeLoss	-2280000
CY1997	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	60000
CY1997	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2000
CY1998	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	12726000
CY1998	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	25000
CY1998	us-gaap	Net Income Loss NetIncomeLoss	-3331000
CY1998	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1202000
CY1998	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	150000
CY1999	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	534000
CY1999	us-gaap	Net Income Loss NetIncomeLoss	-5679000
CY1999	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	995000
CY2001	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	78030000
CY2001	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	13000
CY2001	us-gaap	Net Income Loss NetIncomeLoss	-48245000
CY2001	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1565000
CY2001	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	239000
CY2001	mnkd	Notes Receivable From Stockholders Accrued Interest On Notes NotesReceivableFromStockholdersAccruedInterestOnNotes	189000
CY2001	mnkd	Stock Issued During Period Value Services StockIssuedDuringPeriodValueServices	60000
CY2001	mnkd	Notes Receivable From Stockholders Payments NotesReceivableFromStockholdersPayments	28000
CY2001	mnkd	Adjustments To Additional Paid In Capital Cash Received From Common Stock AdjustmentsToAdditionalPaidInCapitalCashReceivedFromCommonStock	3900000
CY2001	mnkd	Adjustments To Additional Paid In Capital Merger AdjustmentsToAdditionalPaidInCapitalMerger	171154000
CY2001	mnkd	Adjustments To Additional Paid In Capital Put Option Issue AdjustmentsToAdditionalPaidInCapitalPutOptionIssue	2949000
CY2002	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	58815000
CY2002	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	1421000
CY2002	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	84000
CY2002	us-gaap	Net Income Loss NetIncomeLoss	-206265000
CY2002	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	268000
CY2002	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	251000
CY2002	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	151400000
CY2002	mnkd	Notes Receivable From Stockholders Accrued Interest On Notes NotesReceivableFromStockholdersAccruedInterestOnNotes	229000
CY2002	mnkd	Notes Receivable From Stockholders Payments NotesReceivableFromStockholdersPayments	1314000
CY2002	mnkd	Adjustments To Additional Paid In Capital Cash Received From Common Stock AdjustmentsToAdditionalPaidInCapitalCashReceivedFromCommonStock	98000
CY2002	mnkd	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature Deemed Dividend AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeatureDeemedDividend	1421000
CY2002	mnkd	Adjustments To Additional Paid In Capital Put Option Redemption AdjustmentsToAdditionalPaidInCapitalPutOptionRedemption	1921000
CY2003	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	50000000
CY2003	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	1017000
CY2003	us-gaap	Net Income Loss NetIncomeLoss	-65879000
CY2003	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4501000
CY2003	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	253000
CY2003	mnkd	Notes Receivable From Stockholders Accrued Interest On Notes NotesReceivableFromStockholdersAccruedInterestOnNotes	105000
CY2003	mnkd	Stock Issued During Period Value Cash StockIssuedDuringPeriodValueCash	31847000
CY2003	mnkd	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature Deemed Dividend AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeatureDeemedDividend	1017000
CY2003	mnkd	Adjustments To Additional Paid In Capital Non Cash Compensation AdjustmentsToAdditionalPaidInCapitalNonCashCompensation	70000
CY2003	mnkd	Adjustments To Additional Paid In Capital Put Option Sales AdjustmentsToAdditionalPaidInCapitalPutOptionSales	623000
CY2005	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	170234000
CY2005	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1951000
CY2005	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-145000
CY2005	us-gaap	Net Income Loss NetIncomeLoss	-114338000
CY2005	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	495000
CY2005	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	-1828000
CY2005	mnkd	Stock Issued During Period Value Exchange Of Warrants StockIssuedDuringPeriodValueExchangeOfWarrants	245000
CY2006	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	384670000
CY2006	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2312000
CY2006	us-gaap	Net Income Loss NetIncomeLoss	-230548000
CY2006	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-340000
CY2006	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	981000
CY2006	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	14667000
CY2006	mnkd	Stock Issued During Period Value Research Agreement StockIssuedDuringPeriodValueResearchAgreement	2074000
CY2006	mnkd	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	2694000
CY2007	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	249750000
CY2011	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.32
CY2007	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4923000
CY2007	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	123000
CY2007	us-gaap	Net Income Loss NetIncomeLoss	-293190000
CY2007	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-524000
CY2007	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1065000
CY2007	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	17522000
CY2007	mnkd	Stock Issued During Period Value Research Agreement StockIssuedDuringPeriodValueResearchAgreement	944000
CY2009	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	59724000
CY2009	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-581000
CY2009	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	383000
CY2009	us-gaap	Net Income Loss NetIncomeLoss	-220104000
CY2009	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-7001000
CY2009	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	5000
CY2009	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1400000
CY2009	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	20219000
CY2011	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350	pure
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.050	pure
CY2011	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.300	pure
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.04
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2011	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-123837000
CY2011	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes		pure
CY2011	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	34048852	shares
CY2011	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	282816	shares
CY2011	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y9M18D
CY2011	us-gaap	Sales Revenue Net SalesRevenueNet	50000
CY2011	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	9540000
CY2011	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6858000
CY2011	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-27000
CY2011	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	628000
CY2011	us-gaap	Investment Income Interest InvestmentIncomeInterest	18000
CY2011	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-87000
CY2011	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-160804000
CY2011	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	250000
CY2011	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1541000
CY2011	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-27000
CY2011	us-gaap	Interest Paid InterestPaid	17248000
CY2011	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	57200000
CY2011	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-160804000
CY2011	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-224000
CY2011	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-160834000
CY2011	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	3000
CY2011	us-gaap	Operating Income Loss OperatingIncomeLoss	-140539000
CY2011	us-gaap	Gain Loss On Foreign Currency Derivatives Recorded In Earnings Net GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet	1300000
CY2011	us-gaap	Net Income Loss NetIncomeLoss	-160804000
CY2011	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-543000
CY2011	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-3000
CY2011	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-30000
CY2011	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	11116000
CY2011	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	769000
CY2011	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11204000
CY2011	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit
CY2011	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	40630000
CY2011	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1300000
CY2011	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	63394000
CY2011	us-gaap	Share Based Compensation ShareBasedCompensation	11204000
CY2011	us-gaap	Depreciation And Amortization DepreciationAndAmortization	15912000
CY2011	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-63380000
CY2011	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit
CY2011	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	766000
CY2011	us-gaap	Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions	625000
CY2011	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit
CY2011	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	777000
CY2011	us-gaap	Interest Expense Debt InterestExpenseDebt	10941000
CY2011	us-gaap	Operating Expenses OperatingExpenses	140589000
CY2011	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-57225000
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	443000
CY2011	us-gaap	Interest Expense InterestExpense	21800000
CY2011	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2672000
CY2011	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	93000
CY2011	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	48643000
CY2011	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	99959000
CY2011	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	1700000
CY2011	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	8582000
CY2011	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	14600000
CY2011	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	53000000
CY2011	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit
CY2011	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	3828000
CY2011	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit
CY2011	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11204000
CY2011	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit
CY2011	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2937000
CY2011	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	6045000
CY2011	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	10883000
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	1600000
CY2011	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	400000
CY2011	mnkd	Basic And Diluted Weighted Average Number Of Shares Outstanding BasicAndDilutedWeightedAverageNumberOfSharesOutstanding	121817000	shares
CY2011	mnkd	Gain Loss On Sale Abandonment Disposal Or Impairment Of Property And Equipment GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment	4000
CY2011	mnkd	Restructuring Charges Net Of Tax RestructuringChargesNetOfTax	6300000
CY2011	mnkd	Payment Of Employment Taxes Related To Vested Restricted Stock Units PaymentOfEmploymentTaxesRelatedToVestedRestrictedStockUnits	547000
CY2011	mnkd	Effective Income Tax Rate Reconciliation Permanent Items EffectiveIncomeTaxRateReconciliationPermanentItems		pure
CY2011	mnkd	Cancellation Of Principal On Note Payable To Related Party CancellationOfPrincipalOnNotePayableToRelatedParty	11116000
CY2011	mnkd	State Research And Development Credit Exchange Receivable StateResearchAndDevelopmentCreditExchangeReceivable	830000
CY2011	mnkd	Proceeds From Issuance Of Common Stock And Warrants Net ProceedsFromIssuanceOfCommonStockAndWarrantsNet	10941000
CY2011	mnkd	Payments For Use Of Aircrafts PaymentsForUseOfAircrafts	111000
CY2011	mnkd	Income Tax Expense Benefit Net IncomeTaxExpenseBenefitNet
CY2013	dei	Trading Symbol TradingSymbol	MNKD
CY2013	dei	Entity Registrant Name EntityRegistrantName	MANNKIND CORP
CY2013	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2013	dei	Amendment Flag AmendmentFlag	false
CY2013	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2013	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
CY2013	dei	Document Type DocumentType	10-K
CY2013	dei	Document Period End Date DocumentPeriodEndDate	2013-12-31
CY2013	dei	Entity Central Index Key EntityCentralIndexKey	0000899460
CY2013	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2013	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2013	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2013	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.93
CY2013	us-gaap	Line Of Credit Facility Expiration Date1 LineOfCreditFacilityExpirationDate1	2019-12-09
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	10.65
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	187986	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	3.36
CY2013	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350	pure
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	6.63
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.043	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	2861059	shares
CY2013	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	3.82
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.307	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.26
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-128732000
CY2013	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	881139	shares
CY2013	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><i>Concentration of Credit Risk</i> — Financial instruments which potentially subject the Company to concentration of credit risk consist of cash and cash equivalents. Cash and cash equivalents consist of interest-bearing accounts, which are regularly monitored by management and held in high credit quality institutions.</font></p> </div>
CY2013	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes		pure
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage	0.25	pure
CY2013	us-gaap	Line Of Credit Facility Date Of First Required Payment1 LineOfCreditFacilityDateOfFirstRequiredPayment1	2016-07-01
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	287374	shares
CY2013	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	78475367	shares
CY2013	us-gaap	Use Of Estimates UseOfEstimates	<div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><i>Financial Statement Estimates</i> — The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. Management considers many factors in selecting appropriate financial accounting policies and controls, and in developing the estimates and assumptions that are used in the preparation of these financial statements. Management must apply significant judgment in this process. The more significant estimates reflected in these accompanying financial statements involve assessing long-lived assets for impairment, accrued expenses, including clinical trial expenses, valuation of forward purchase contracts, valuation of Milestone Rights, valuation of the Commitment Asset, valuation of stock-based compensation and the determination of the provision for income taxes and corresponding deferred tax assets and liabilities and any valuation allowance recorded against net deferred tax assets.</font></p> </div>
CY2013	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.64
CY2013	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	463290	shares
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.60
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	6919900	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.93
CY2013	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y7M6D
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y10M2D
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	265610	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	8481459	shares
CY2013	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	48888000
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7987000
CY2013	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	6500000
CY2013	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2270000
CY2013	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	598000
CY2013	us-gaap	Investment Income Interest InvestmentIncomeInterest	8000
CY2013	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	115000000
CY2013	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-191490000
CY2013	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	856000
CY2013	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-635000
CY2013	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	998000
CY2013	us-gaap	Interest Paid InterestPaid	13452000
CY2013	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	66800000
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-191490000
CY2013	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	965000
CY2013	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	16000000
CY2013	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-191488000
CY2013	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-2000
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	-169401000
CY2013	us-gaap	Net Income Loss NetIncomeLoss	-191490000
CY2013	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-4801000
CY2013	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	2000
CY2013	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2000
CY2013	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1263000
CY2013	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	45186000
CY2013	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	7886000
CY2013	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit
CY2013	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	59682000
CY2013	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1400000
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	145669000
CY2013	us-gaap	Line Of Credit Facility Annual Principal Payment LineOfCreditFacilityAnnualPrincipalPayment	28375000
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	45186000
CY2013	us-gaap	Depreciation And Amortization DepreciationAndAmortization	14057000
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	8950000
CY2013	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit
CY2013	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	645000
CY2013	us-gaap	Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions	2300000
CY2013	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit
CY2013	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	533000
CY2013	us-gaap	Interest Expense Debt InterestExpenseDebt	15153000
CY2013	us-gaap	Operating Expenses OperatingExpenses	169401000
CY2013	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-66849000
CY2013	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	94147000
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	3100000
CY2013	us-gaap	Interest Expense InterestExpense	21500000
CY2013	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1071000
CY2013	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	59379000
CY2013	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	109719000
CY2013	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	119500000
CY2013	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	591000
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	13900000
CY2013	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	7470000
CY2013	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11500000
CY2013	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit
CY2013	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit
CY2013	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit
CY2013	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	45186000
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7987000
CY2013	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	6309000
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	14900000
CY2013	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	400000
CY2013	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	3675000
CY2013	mnkd	Basic And Diluted Weighted Average Number Of Shares Outstanding BasicAndDilutedWeightedAverageNumberOfSharesOutstanding	299591000	shares
CY2013	mnkd	Amortization Period Of Lease Hold Improvements AmortizationPeriodOfLeaseHoldImprovements	P4Y
CY2013	mnkd	Stock Options Granted Vesting Rate StockOptionsGrantedVestingRate	0.25	pure
CY2013	mnkd	Stock Issued During Period Value Warrant Exercises StockIssuedDuringPeriodValueWarrantExercises	172149000
CY2013	mnkd	Gain Loss On Sale Abandonment Disposal Or Impairment Of Property And Equipment GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment	-817000
CY2013	mnkd	Payment Of Employment Taxes Related To Vested Restricted Stock Units PaymentOfEmploymentTaxesRelatedToVestedRestrictedStockUnits	4801000
CY2013	mnkd	Percentage Of Credit Exchange Receivable PercentageOfCreditExchangeReceivable	0.65	pure
CY2013	mnkd	Stock Issued During Period Value For Debt Exchange StockIssuedDuringPeriodValueForDebtExchange	5501000
CY2013	mnkd	Maturity Period Of Cash Equivalents MaturityPeriodOfCashEquivalents	90 days or less at the time of purchase
CY2013	mnkd	Effective Income Tax Rate Reconciliation Permanent Items EffectiveIncomeTaxRateReconciliationPermanentItems		pure
CY2013	mnkd	Value Of Restricted Stock Units Vested ValueOfRestrictedStockUnitsVested	45600000
CY2013	mnkd	Income Tax Expense Benefit Net IncomeTaxExpenseBenefitNet
CY2013	mnkd	Cancellation Of Principal On Note Payable To Related Party CancellationOfPrincipalOnNotePayableToRelatedParty	78000000
CY2013	mnkd	State Research And Development Credit Exchange Receivable StateResearchAndDevelopmentCreditExchangeReceivable	466000
CY2013	mnkd	Proceeds From Issuance Of Common Stock And Warrants Net ProceedsFromIssuanceOfCommonStockAndWarrantsNet	52421000
CY2013	mnkd	Payments For Use Of Aircrafts PaymentsForUseOfAircrafts	82000
CY2004	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6810000
CY1996	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	59000
CY1996	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	12000
CY1996	us-gaap	Net Income Loss NetIncomeLoss	-2570000
CY1996	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	126000
CY2000	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	31633000
CY2000	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	-993000
CY2000	us-gaap	Net Income Loss NetIncomeLoss	-24661000
CY2000	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1074000
CY2000	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9609000
CY2000	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	149000
CY2000	mnkd	Notes Receivable From Stockholders Accrued Interest On Notes NotesReceivableFromStockholdersAccruedInterestOnNotes	117000
CY2000	mnkd	Adjustments To Additional Paid In Capital Amount In Excess Of Redemption Obligation AdjustmentsToAdditionalPaidInCapitalAmountInExcessOfRedemptionObligation	999000
CY2000	mnkd	Notes Receivable From Stockholders Discount On Notes Below Market Rate NotesReceivableFromStockholdersDiscountOnNotesBelowMarketRate	241000
CY2000	mnkd	Stock Issued During Period Value StockIssuedDuringPeriodValue	15000000
CY2004	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1079000
CY2004	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	19822000
CY2004	us-gaap	Net Income Loss NetIncomeLoss	-75992000
CY2004	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	18153000
CY2004	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	430000
CY2004	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	60000
CY2004	mnkd	Notes Receivable From Stockholders Accrued Interest On Notes NotesReceivableFromStockholdersAccruedInterestOnNotes	107000
CY2004	mnkd	Notes Receivable From Officers Repayment NotesReceivableFromOfficersRepayment	3000
CY2004	mnkd	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature Deemed Dividend AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeatureDeemedDividend	19822000
CY2004	mnkd	Stock Issued During Period Value Conversion Of Convertible Securities Series A StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesSeriesA	5248000
CY2004	mnkd	Stock Issued During Period Value Initial Public Offering StockIssuedDuringPeriodValueInitialPublicOffering	83176000
CY2004	mnkd	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	46000
CY2008	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	295000
CY2008	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-18000
CY2008	us-gaap	Net Income Loss NetIncomeLoss	-303039000
CY2008	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-315000
CY2008	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	900000
CY2008	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	24811000
CY2012	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.040	pure
CY2012	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.310	pure
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.99
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-119860000
CY2012	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes		pure
CY2012	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	128324123	shares
CY2012	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.94
CY2012	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	422260	shares
CY2012	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y9M7D
CY2012	us-gaap	Sales Revenue Net SalesRevenueNet	35000
CY2012	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	637000
CY2012	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-1237000
CY2012	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	9000
CY2012	us-gaap	Investment Income Interest InvestmentIncomeInterest	7000
CY2012	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-169366000
CY2012	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	4072000
CY2012	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1191000
CY2012	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-48000
CY2012	us-gaap	Interest Paid InterestPaid	9755000
CY2012	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	60700000
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-169774000
CY2012	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1545000
CY2012	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-169416000
CY2012	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	2000
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	-146960000
CY2012	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	-117000
CY2012	us-gaap	Net Income Loss NetIncomeLoss	-169366000
CY2012	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-906000
CY2012	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-2000
CY2012	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-50000
CY2012	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	184537000
CY2012	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	862000
CY2012	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13292000
CY2012	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	14219000
CY2012	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	6056000
CY2012	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit
CY2012	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	45473000
CY2012	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1400000
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	179579000
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	13292000
CY2012	us-gaap	Depreciation And Amortization DepreciationAndAmortization	14402000
CY2012	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	59159000
CY2012	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit
CY2012	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	675000
CY2012	us-gaap	Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions	9200
CY2012	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit
CY2012	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	571000
CY2012	us-gaap	Interest Expense Debt InterestExpenseDebt	11139000
CY2012	us-gaap	Operating Expenses OperatingExpenses	146995000
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-408000
CY2012	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-60739000
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1000
CY2012	us-gaap	Interest Expense InterestExpense	21600000
CY2012	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	44000
CY2012	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	77000
CY2012	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	51540000
CY2012	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	101522000
CY2012	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	2900000
CY2012	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	9199000
CY2012	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13000000
CY2012	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	12750000
CY2012	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit
CY2012	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit
CY2012	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13292000
CY2012	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-560000
CY2012	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	48000
CY2012	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	10491000
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	3000000
CY2012	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	300000
CY2012	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	15075000
CY2012	mnkd	Nominal Lending Fee NominalLendingFee	0.01
CY2012	mnkd	Basic And Diluted Weighted Average Number Of Shares Outstanding BasicAndDilutedWeightedAverageNumberOfSharesOutstanding	180855000	shares
CY2012	mnkd	Adjustments To Additional Paid In Capital Net Share Settlement Of Equity Awards AdjustmentsToAdditionalPaidInCapitalNetShareSettlementOfEquityAwards	6056000
CY2012	mnkd	Gain Loss On Sale Abandonment Disposal Or Impairment Of Property And Equipment GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment	-682000
CY2012	mnkd	Stock Issued During Period Value Issued Related To Legal Settlement StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement	438000
CY2012	mnkd	Payment Of Employment Taxes Related To Vested Restricted Stock Units PaymentOfEmploymentTaxesRelatedToVestedRestrictedStockUnits	906000
CY2012	mnkd	Effective Income Tax Rate Reconciliation Permanent Items EffectiveIncomeTaxRateReconciliationPermanentItems		pure
CY2012	mnkd	Change In Fair Value Of Forward Exchange Rate Contracts ChangeInFairValueOfForwardExchangeRateContracts	-1237000
CY2012	mnkd	Cancellation Of Principal On Note Payable To Related Party CancellationOfPrincipalOnNotePayableToRelatedParty	184537000
CY2012	mnkd	State Research And Development Credit Exchange Receivable StateResearchAndDevelopmentCreditExchangeReceivable	-290000
CY2012	mnkd	Reclassification Of Forward Purchase Contract To Additional Paid In Capital ReclassificationOfForwardPurchaseContractToAdditionalPaidInCapital	28080000
CY2012	mnkd	Stock Issued During Period Value Initial Public Offering StockIssuedDuringPeriodValueInitialPublicOffering	166864000
CY2012	mnkd	Forward Purchase Contract Contribution To Additional Paid In Capital ForwardPurchaseContractContributionToAdditionalPaidInCapital	29317000
CY2012	mnkd	Loss Contingency Settlement Agreement Stock Issuable LossContingencySettlementAgreementStockIssuable	3002778	shares
CY2012	mnkd	Proceeds From Issuance Of Common Stock And Warrants Net ProceedsFromIssuanceOfCommonStockAndWarrantsNet	167735000
CY2012	mnkd	Common Shares Issued Pursuant To Litigation Settlement CommonSharesIssuedPursuantToLitigationSettlement	438000
CY2012	mnkd	Payments For Use Of Aircrafts PaymentsForUseOfAircrafts	200000
CY2012	mnkd	Income Tax Expense Benefit Net IncomeTaxExpenseBenefitNet
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	900000
	us-gaap	Net Income Loss NetIncomeLoss	-911000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1724993000
	us-gaap	Sales Revenue Net SalesRevenueNet	3166000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	335733000
	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	6500000
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-1237000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	48000
	us-gaap	Income Taxes Paid IncomeTaxesPaid	26000
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	598000
	us-gaap	Investment Income Interest InvestmentIncomeInterest	37004000
	us-gaap	Stock Issued1 StockIssued1	2758000
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	230000
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	796779000
	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	115000000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2319614000
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1667000
	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	856000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2902000
	us-gaap	Interest Paid InterestPaid	72604000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-2296784000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3535000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2296406000
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1101000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2230666000
	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	-990000
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	70000000
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1028000
	us-gaap	Net Income Loss NetIncomeLoss	-2296402000
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-4000
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4000
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	3331000
	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	22105000
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	6056000
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	5248000
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	3460000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	485386000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2131448000
	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	952000
	us-gaap	Share Based Compensation ShareBasedCompensation	183104000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	140834000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	70790000
	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	15000000
	us-gaap	Interest Expense Debt InterestExpenseDebt	55086000
	us-gaap	Operating Expenses OperatingExpenses	2233832000
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	207050000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-382000
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	1742000
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	94147000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3347000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3900000
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	454000
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	1577292000
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	119500000
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	589000
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	4220000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	133300000
	us-gaap	Preferred Stock Conversions Inducements PreferredStockConversionsInducements	22260000
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	387750000
	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	19726000
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	151428000
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	796393000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-335665000
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	48000
	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	45134000
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	38724000
	mnkd	Collection Of Convertible Preferred Stock Subscriptions Receivable CollectionOfConvertiblePreferredStockSubscriptionsReceivable	50000000
	mnkd	Accrued Interest On Investments Net Of Amortization Of Discounts AccruedInterestOnInvestmentsNetOfAmortizationOfDiscounts	191000
	mnkd	Gain Loss On Sale Abandonment Disposal Or Impairment Of Property And Equipment GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment	-25070000
	mnkd	Payment Of Employment Taxes Related To Vested Restricted Stock Units PaymentOfEmploymentTaxesRelatedToVestedRestrictedStockUnits	17828000
	mnkd	Issuance Of Put Option By Stockholder IssuanceOfPutOptionByStockholder	2949000
	mnkd	Put Option Redemption By Stockholder PutOptionRedemptionByStockholder	1921000
	mnkd	Stock Expense For Shares Issued Pursuant To Research Agreement StockExpenseForSharesIssuedPursuantToResearchAgreement	3018000
	mnkd	Put Shares Sold To Majority Stockholder PutSharesSoldToMajorityStockholder	623000
	mnkd	Cancellation Of Principal On Note Payable To Related Party CancellationOfPrincipalOnNotePayableToRelatedParty	290334000
	mnkd	Issuance Of Redeemable Convertible Preferred Stock IssuanceOfRedeemableConvertiblePreferredStock	4296000
	mnkd	State Research And Development Credit Exchange Receivable StateResearchAndDevelopmentCreditExchangeReceivable	-297000
	mnkd	Reclassification Of Forward Purchase Contract To Additional Paid In Capital ReclassificationOfForwardPurchaseContractToAdditionalPaidInCapital	28080000
	mnkd	Forward Purchase Contract Contribution To Additional Paid In Capital ForwardPurchaseContractContributionToAdditionalPaidInCapital	29317000
	mnkd	Increase In Additional Paid In Capital Resulting From Merger IncreaseInAdditionalPaidInCapitalResultingFromMerger	171154000
	mnkd	Issuance Of Convertible Preferred Stock Subscriptions IssuanceOfConvertiblePreferredStockSubscriptions	50000000
	mnkd	Proceeds From Issuance Of Common Stock And Warrants Net ProceedsFromIssuanceOfCommonStockAndWarrantsNet	1450177000
	mnkd	Common Shares Issued Pursuant To Litigation Settlement CommonSharesIssuedPursuantToLitigationSettlement	438000
CY2013Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.15
CY2013Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-40965000
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	-40965000
CY2013Q1	mnkd	Basic And Diluted Weighted Average Number Of Shares Outstanding BasicAndDilutedWeightedAverageNumberOfSharesOutstanding	280058000	shares
CY2012Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.27
CY2012Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-38173000
CY2012Q1	us-gaap	Net Income Loss NetIncomeLoss	-38173000
CY2012Q1	mnkd	Basic And Diluted Weighted Average Number Of Shares Outstanding BasicAndDilutedWeightedAverageNumberOfSharesOutstanding	143154000	shares
CY2012Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.23
CY2012Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-36578000
CY2012Q2	us-gaap	Net Income Loss NetIncomeLoss	-36578000
CY2012Q2	mnkd	Basic And Diluted Weighted Average Number Of Shares Outstanding BasicAndDilutedWeightedAverageNumberOfSharesOutstanding	159859000	shares
CY2013Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.16
CY2013Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-46124000
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	-46124000
CY2013Q2	mnkd	Basic And Diluted Weighted Average Number Of Shares Outstanding BasicAndDilutedWeightedAverageNumberOfSharesOutstanding	284044000	shares
CY2013Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.17
CY2013Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-50818000
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	-50818000
CY2013Q3	mnkd	Basic And Diluted Weighted Average Number Of Shares Outstanding BasicAndDilutedWeightedAverageNumberOfSharesOutstanding	296386000	shares
CY2012Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.22
CY2012Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-42834000
CY2012Q3	us-gaap	Net Income Loss NetIncomeLoss	-42834000
CY2012Q3	mnkd	Basic And Diluted Weighted Average Number Of Shares Outstanding BasicAndDilutedWeightedAverageNumberOfSharesOutstanding	190534000	shares
CY2012Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.23
CY2012Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-51781000
CY2012Q4	us-gaap	Net Income Loss NetIncomeLoss	-51781000
CY2012Q4	mnkd	Basic And Diluted Weighted Average Number Of Shares Outstanding BasicAndDilutedWeightedAverageNumberOfSharesOutstanding	229234000	shares
CY2013Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.16
CY2013Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-53582000
CY2013Q4	us-gaap	Net Income Loss NetIncomeLoss	-53582000
CY2013Q4	mnkd	Basic And Diluted Weighted Average Number Of Shares Outstanding BasicAndDilutedWeightedAverageNumberOfSharesOutstanding	337284000	shares

Files In Submission

Name	View Source	Status
0001193125-14-080324-index-headers.html	Edgar Link	pending
0001193125-14-080324-index.html	Edgar Link	pending
0001193125-14-080324.txt	Edgar Link	pending
0001193125-14-080324-xbrl.zip	Edgar Link	pending
d647959d10k.htm	Edgar Link	pending
d647959dex1031.htm	Edgar Link	pending
d647959dex1032.htm	Edgar Link	pending
d647959dex1039.htm	Edgar Link	pending
d647959dex231.htm	Edgar Link	pending
d647959dex311.htm	Edgar Link	pending
d647959dex312.htm	Edgar Link	pending
d647959dex32.htm	Edgar Link	pending
d647959dex47.htm	Edgar Link	pending
d647959dex51.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
g647959ex5_1pg01.jpg	Edgar Link	pending
g647959g43t61.jpg	Edgar Link	pending
mnkd-20131231.xml	Edgar Link	completed
mnkd-20131231.xsd	Edgar Link	pending
mnkd-20131231_cal.xml	Edgar Link	unprocessable
mnkd-20131231_def.xml	Edgar Link	unprocessable
mnkd-20131231_lab.xml	Edgar Link	unprocessable
mnkd-20131231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MNKD
MANNKIND CORP Stock $mnkd

2014 Q1 Form 10-K Financial Statement

#000119312514080324 Filed on March 03, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MNKD MANNKIND CORP Stock $mnkd

2014 Q1 Form 10-K Financial Statement

#000119312514080324 Filed on March 03, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MNKD
MANNKIND CORP Stock $mnkd